Latin America is the latest region to benefit from Merck & Co.'s antiretroviral price cuts

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.318, 2001-01, pp. : 12-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Merck & Co. has substantially cut the price of 2 of its antiretroviral agents in Mexico

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 315, 2001-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Antiretroviral coverage in Africa improved by donors and price cuts

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 618, 2010-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

COX-2s confer QOL benefit in clinical practice in Latin America

Inpharma, Vol. 1, Iss. 1448, 2004-01 ,pp. : 5-6

Adis International

Access to resources Recommend Favorite

COX-2s confer QOL benefit in clinical practice in Latin America

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 458, 2004-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite

GSK cuts HIV/AIDS drug prices, Latin America cuts drug deal

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 418, 2003-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite